Detection of serum transforming growth factor-α in patients of primary epithelial ovarian cancers by enzyme immunoassay

Gynecologic Oncology

Volumn 66, Issue 3, 1997, Pages 405-410

  Chien, Chin Hsiang ^a   Huang, Chien Chu ^b   Lin, Yu Hung ^b   Shen, Jenta ^c   Chow, Song Nan ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKER;

ARTICLE; AUTOCRINE EFFECT; BLOOD LEVEL; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0031239992     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4794     Document Type: Article

References (47)

1. 1. Wharten JT, Edwards CL, Rutledge FN: Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma. Am J Obstet Gynecol 148:997-1005, 1984
2. 2. Hainsworth JD, Grosh WW, Burnet LS, Jones HW, Wolff SN, Greco FA: Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration. Ann Intern Med 108:165-170, 1988
3. 3. Chen CK, Chow SN, Chen RJ, Chen YP, Huang LC, Wang LI, Lin YH, Huang SC: Primary ovarian cancer at National Taiwan University Hospital: 1980-1989. Int Surg 79:48-51, 1994
4. 4. Chow SN, Chen YP: Primary ovarian cancer. Int Surg 72:154-159, 1987
5. 5. Chow SN, Yang JH, Lin YH, Chen YP, Lai JI, Chen RJ, Chen CD: Malignant ovarian germ cell tumors. Int J Gynecol Obstet 53:151-158, 1996
6. 6. Bauknecht T, Birmelin G, Kommoss F: Clinical significance of oncogenes and growth factors in ovarian carcinomas. J Steroid Biochem Mol Biol 37:855-862, 1990
7. 7. Chow SN, Chien CH, Chen CT: Molecular biology of human ovarian cancer. Int Surg 81:152-157, 1996
8. 8. Chow SN, Lin JK, Li S-SL, Chien CH: Identification of LDH-ras p21 protein complex and expression of these genes in human ovarian cancer. Gynecol Oncol 64:114-120, 1997
9. 9. Anzano MA, Roberts AB, Smith JM, Sporn MB, De Larco JE: Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci USA 80:6264-6268, 1983
10. 10. Derynck R: Transforming growth factor-α: structure and biological activities. J Cell Biochem 32:203-204, 1986
11. 11. Derynck R: Transforming growth factor. Cell 54:593-595, 1988
12. 12. Todaro GL, Marquardt H, Twadrdzik DR, Reynolds FH Jr, Stephenson JR: Transforming Growth Factors Produced by Viral-Transformed and Human Tumor Cells. in Vogel H, Weinstein IB (eds): Genes and Proteins in Oncogenesis, New York, Raven Press, 1984, pp 165-182
13. 13. Derynck R, Goeddle DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS: Synthesis of messenger RNAs from transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712, 1987
14. 14. Wilcox J, Derynck R: Developmental expression of transforming growth factor α and β in mouse fetus. Mol Cell Biol 8:3415-3422, 1988
15. 15. Sporn MB, Roberts AB: Autocrine growth factors and cancer. Nature 313:747-751, 1985
16. 16. Massaque J: Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A341 cells. J Biol Chem 258:13614-13620, 1983
17. 17. Pike LT, Marquardt H, Todaro GL, Gallis B, Casuelli J, Bornstein P, Kerbs E: Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner. J Biol Chem 257:14628-14631, 1982
18. 18. Reynolds FH Jr, Todaro GJ, Fryling C, Stephenson JR: Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature 292:259-262, 1981
19. 19. Yeh YC, Tsai JF, Chung LY, Yeh HW, Tasi JH, Florine DJ, Tam JP: Elevation of transforming growth factor α and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res 47:896-901, 1987
20. 20. Arteaga CL, Hanauske AR, Clark GM, Osborne CK, Hazarika P, Pardue RL, Tio F, von Hoff DD: Immunoreactive α transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. Cancer Res 48:5023-5028, 1988
21. 21. Katoh M, Inagaki H, Kurosawa-Ohsawa K, Katsuura M, Tanaka S: Detection of transforming growth factor α in human urine and plasma. Biochem Biophys Res Commun 167:1065-1072, 1990
22. 22. Muller R, Bravo R, Burckhardt J, Curran T: Induction of c-fos and protein by growth factors precedes activation of c-myc. Nature 312:716-720, 1984
23. 23. International Federation of Gynecology and Obstetrics (FIGO). Changes in definitions of clinical staging for cervix and ovary. Am J Obstet Gynecol 156:263-264, 1987
24. 24. Chow SN, Hsieh CY, Ouyang PC, Leung WY, Ho YB, Lee CYG: Studies of monoclonal antibodies against human chorionic gonadotropin. II. Applications of human chorionic gonadotropin monoclonal antibodies on immunoassays. Diagn Immunol 4:194-200, 1986
25. 25. Chow SN, Chen KW, Su SL, Tung J, Lee CYG: Generation and epitope analysis of thyroid stimulation hormone-specific monoclonal antibodies for enzyme immunoassays. Biotechnol Appl Biochem 10:137-142, 1988
26. 26. Crew AJ, Langdon SP, Miller EP, Miller WR: Mitogenic effects of epidermal growth factor and transforming growth factor-α on EGF-receptor positive human ovarian carcinoma cell lines. Eur J Cancer 28:337-341, 1992
27. 27. Morishige K, Kurachi H, Amemiya K, Adachi H, Inoue M, Miyake A, Tanizawa O, Sakoyama Y: Involvement of transforming growth factor α/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro. Cancer Res 51:5951-5955, 1991
28. 28. Kurachi H, Morishige K, Amemiya K, Adachi H, Hirota K, Miyake A, Tanizawa O: Importance of transforming growth factor α/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo. Cancer Res 51:5956-5959, 1991
29. 29. Stromberg K, Collins TJ IV, Gordon AW, Jackson CL, Johnson GR: Transforming growth factor-α acts as an autocrine growth factor in ovarian carcinoma cell lines. Cancer Res 52:341-347, 1992
30. 30. Owens OJ, Stewart C, Leake RE: Growth factors in ovarian cancer. Br J Cancer 64:1177-1181, 1991
31. 31. Morishige K, Kurachi H, Amemiya K, Fujita Y, Yamamoto T, Miyake A, Tanizawa O: Evidence for the involvement of transforing growth factor α and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res 51:5322-5328, 1991
32. 32. Kommoss F, Wintzer HO, Von Kleist S, Kohler M, Walker R, Langton B, Tran KV, Pfleiderer A, Bauknecht T: In situ distribution of transforming growth factor α in normal human tissue and in malignant tumors of the ovary. J Pathol 162:223-230, 1990
33. 33. Bauknecht T, Kommoss F, Birmelin G, Von Kleist S, Kohler M, Pfleiderer A: Expression analysis of EGF-R and TGF-α in human ovarian carcinomas. Anticancer Res 11:1523-1528, 1991
34. 34. Xynos FP, Klos DJ, Hamilton PD, Schuette V, Fernandez-Pol JA: Expression of transforming growth factor alpha mRNA in benign and malignant tissues derived from gynecologic patients with various proliferative conditions. Anticancer Res 12:1115-1120, 1992
35. 35. Kommoss F, Bauknecht T, Bermelin G, Kohler M, Tesch H, Pfleiderer A: Oncogene and growth factor expression in ovarian cancer. Acta Obstet Gynecol Scand (71 Suppl) 155:19-24, 1992
36. 36. Jindal SK, Snoey DM, Lobb DK, Dorrington JH: Transforming growth factor alpha localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol Oncol 53:17-23, 1994
37. 37. Feldkamper M, Enderle-Schmitt U, Hackenberg R, Schulz KD: Urinary excretion of growth factors in patients with ovarian cancer. Eur J Cancer 30A:1851-1858, 1994
38. 38. Bauknecht T, Angel P, Kohler M, Kommoss F, Birmelin G, Pfleiderer A, Wagner E: Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Cancer 71:419-429, 1993
39. 39. Marth C, Cronauer MV, Doppler W, Ofner D, Ullrich A, Daxenbichler G: Effects of interferons the expression of the proto-oncogene Her-2 in human ovarian carcinoma cells. Int J Cancer 50:64-68, 1992
40. 40. Marth C, Muller-Hlozner E, Zeimet AG, Greiter E, Cronauer MV, Doppler W, Eibl B, Hynes NE, Daxenbichler G: Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells. Gynakol Geburtshilfliche Rundsch 32:31-34, 1992
41. 41. Meden H, Marx D, Rath W, Kuhn W, Hinney B, Schauer A: Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients. Geburtshilfe u Frauenheilk 52:667-673, 1992
42. 42. Meden H, Marx D, Raab T, Kron M, Schauer A, Kuhn W: EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value. J Obstet Gynecol 21:167-178, 1995
43. 43. Nagai N: Evaluation of prognostic factors in gynecological cancer examined by molecular biological study. Jpn J Cancer Chemother 23:1004-1009, 1996
44. 44. Brandt B, Vogt U, Schlotter CM, Jackisch C, Werkmeister R, Thomas M, von Eiff M, Bosse U, Assmann G, Zanker KS: Prognostic relevance of abberations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene 159:35-42, 1995
45. 45. Simpson BJ, Phillips HA, Lesselles AM, Langdon SP, Miller WR: c-erbB growth-factor-receptor proteins in ovarian tumors. Int J Cancer 64:202-206, 1995
46. 46. Marth C, Muller-Holzner E, Greiter E, Cronauer MV, Zeimet AG, Doppler W, Eibl B, Hynes NE, Daxenbichler G: Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells. Cancer Res 50:7037-7041, 1990
47. 47. Nehme A, Albin N, Caliaro MJ, Guichard S, Jozan S, Julia AM, Bugat R, Canal P: Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian cancer cell lines. Int J Cancer 61:643-648, 1995